CIBC Private Wealth Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Sell |
|
|||||
|
2025
Q1 | $1.91M | Buy |
|
|||||
|
2024
Q4 | $2.56M | Sell |
|
|||||
|
2024
Q3 | $30.2M | Buy |
|
|||||
|
2024
Q2 | $31M | Buy |
|
|||||
|
2024
Q1 | $39.9M | Buy |
|
|||||
|
2023
Q4 | $34.7M | Buy |
|
|||||
|
2023
Q3 | $28.7M | Sell |
|
|||||
|
2023
Q2 | $30.9M | Buy |
|
|||||
|
2023
Q1 | $20.8M | Sell |
|
|||||
|
2022
Q4 | $22M | Sell |
|
|||||
|
2022
Q3 | $20.4M | Buy |
|
|||||
|
2022
Q2 | $21.8M | Sell |
|
|||||
|
2022
Q1 | $29.4M | Buy |
|
|||||
|
2021
Q4 | $38M | Buy |
|
|||||
|
2021
Q3 | $40.9M | Buy |
|
|||||
|
2021
Q2 | $29.4M | Sell |
|
|||||
|
2021
Q1 | $23.6M | Sell |
|
|||||
|
2020
Q4 | $21.1M | Sell |
|
|||||
|
2020
Q3 | $19.3M | Sell |
|
|||||
|
2020
Q2 | $15.1M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $288K | Hold |
|
|||||
|
2019
Q3 | $250K | Hold |
|
|||||
|
2019
Q2 | $267K | Hold |
|
|||||
|
2019
Q1 | $274K | Hold |
|
|||||
|
2018
Q4 | $213K | Hold |
|
|||||
|
2018
Q3 | $254K | Hold |
|
|||||
|
2018
Q2 | $212K | Buy |
|